Pharmaceutical Technology Europe-11-01-2006

Pharmaceutical Technology Europe

Understanding powder behaviour by measurig bulk, flow and shear properties

November 01, 2006

Formulation

18

11

The trend towards developing pharmaceutical products and their manufacturing processes in tandem supports optimized production. Such developments rely on gathering process-relevant information at an early stage and being able to draw on past and current processing experience. Here, we discuss how powder rheometers can make a real difference in building a database of powder properties and removing subjectivity.

The development of PAT in biotech manufacturing

November 01, 2006

PAT

18

11

Quality by design and PAT approaches are increasingly being used for the biotech manufacturing of medicines. Complex manufacturing processes can not only be controlled using PAT principles, but optimized with respect to both product quality and economic value. This column describes how the fermentation process is often the first to benefit from this type of implementation.

Pharmaceutical packaging and labelling for blind and partially sighted people

November 01, 2006

Packaging & Labelling

18

11

A European Commission directive requires suppliers to incorporate information on medicines in formats suitable for blind and partially sighted people, although the associated standard has not been introduced yet. This article looks at some of the issues that will need to be addressed when the standard is adopted.

Terahertz applications for the analysis of solid dosage forms

November 01, 2006

Analytical

18

11

This article investigates pharmaceutical applications of terahertz technology, specifically using techniques for solid dosage form analysis such as pulsed spectroscopy (to generate physical information and detect API changes) and pulsed imaging (to locate formulation impurities, and regulate tablet coating quality and thickness).